HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

4th Edition of Global Conference on Gynecology & Women's Health

September 28-30, 2026 | London, UK

Precancerous Cervical Lesion

Precancerous Cervical Lesion

 

Precancerous cervical lesions, also known as cervical intraepithelial neoplasia (CIN), are identified as the abnormal growth of cells on the surface of the cervix. CIN is caused by infection of the human papillomavirus (HPV), which can lead to the development of cervical cancer if left untreated. CIN is classified into three grades: CIN 1, CIN 2, and CIN 3. CIN 1 is the most benign, and CIN 3 is the most severe. CIN 1 is characterized by mild changes in the cells of the lower one-third of the cervix, while CIN 2 and 3 involve changes in the cells of the lower two-thirds. The diagnosis of CIN is made through a Pap smear, which is a sample of cells taken from the cervix and examined under a microscope. In some cases, a biopsy of the cervix may be required to confirm the diagnosis. Treatment for CIN depends on the severity of the lesion. In most cases, CIN 1 can be treated with careful monitoring and observation, while CIN 2 and 3 may require more aggressive treatments, such as cryotherapy, laser therapy, or loop electrosurgical excision procedure (LEEP). It is important to note that CIN does not always progress to cancer, and in some cases, it may resolve itself without treatment. However, it is important to seek medical advice if there is any suspicion of CIN, as early detection and treatment are key to preventing the progression to cervical cancer.

 

Submit your abstract Today

Watsapp